Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells

Roland Frötschl1, Sandra Weickardt, Solveig Staszewski

  • 1Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany. r.froetschl@bfarm.de

Mutation Research
|June 1, 2005
PubMed

Insights

UV-activated chlorpromazine (CPZ) causes DNA damage and alters gene expression in HepG2 cells, primarily affecting cell cycle regulation. Gene expression changes show distinct peaks at 7 and 23 hours post-treatment.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Genetics

Background:

  • DNA damage triggers stress signals altering gene expression in biological pathways.
  • Chlorpromazine (CPZ) becomes genotoxic upon UV irradiation, producing DNA-damaging free radicals.

Purpose of the Study:

  • To identify genes regulated by UV-activated CPZ-induced DNA damage in HepG2 cells.
  • To characterize the time-dependent gene expression profile following photogenotoxicity.

Main Methods:

  • Utilized a cDNA microarray of 1089 genes related to DNA damage, repair, cell cycle, and metabolism.
  • Assessed genotoxicity using the Comet assay concurrently with gene expression profiling.
  • Performed kinetic studies at four time points (3, 7, 15, 23 hours) post-treatment.

Main Results:

  • Observed a time-dependent pattern of gene expression changes, with peaks at 7 and 23 hours.
  • Most differentially expressed genes were involved in cell cycle regulation and proliferation.
  • Gene expression profiles showed low concordance with those from other genotoxic compounds due to differing experimental conditions.

Conclusions:

  • UV-activated CPZ induces significant alterations in gene expression related to cell cycle and proliferation in HepG2 cells.
  • The study highlights the importance of experimental conditions in gene expression profiling for genotoxicity assessment.